Table 2.
Univariate and multivariate analyses for OS prediction in validation cohort. HR, hazard ratio
| Parameters | Categories | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| Age (years) | ≤ 61, > 61 | 1.335 (0.803–2.220) | 0.265 | ||
| Sex | Male, female | 0.586 (0.330–1.040) | 0.068 | ||
| Tumor size | ≤ 3 cm, > 3 cm | 3.071 (1.720–5.481) | < 0.001 | 1.375 (0.725–2.607) | 0.329 |
| Lymph node metastasis | Negative, positive | 4.530 (2.570–7.983) | < 0.001 | 1.638 (0.745–3.601) | 0.220 |
| TNM stage | I, II, III | 2.788 (1.961–3.966) | < 0.001 | 1.859 (1.089–3.175) | 0.023 |
| SOX2OT expression | Low, high | 1.988 (1.187–3.330) | 0.009 | 1.793 (1.040–3.093) | 0.036 |
| ANRIL expression | Low, high | 1.856 (1.108–3.109) | 0.019 | 1.507 (0.874–2.598) | 0.140 |